The Empty Capsules Market is expected to reach a value of USD 3,230 million in 2023 and increase at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2033, when it is expected to reach USD 5,130 million.
The need for plant-based and non-animal-derived capsules is also being fueled by the rise in vegetarian and vegan diets. Continuous research and development endeavors aimed at enhancing capsule quality, stability, and compatibility with diverse formulations are underway.
The market for empty capsules is expected to expand significantly soon. The need for pharmaceutical and nutraceutical goods is predicted to rise, which will drive growth in the empty capsule industry. The market is progressing because to factors such the increased demand for specialized drug delivery systems, improvements in capsule technology, and the growing preference of consumers for easy and customisable dose forms. In addition, the growing number of elderly people and the occurrence of long-term illnesses are driving up demand for empty capsules as the recommended method of taking medications.
Request a Glimpse of Our Sample Report: https://wemarketresearch.com/sample-request/empty-capsules-market/1320
Empty Capsules Market Competitive Outlook
Lonza, Qualicaps, Suheung Co., Ltd, Roxlor Llc, Natural Capsules Limited, Nectar Lifesciences Ltd, Healthcaps India Ltd., Sunil Healthcare Limited, Bright Pharma Caps, Snail Pharma Industry Co. Ltd, Medi-Caps Ltd.
Empty Capsules Market: Drivers
1. Pharmaceutical and nutraceutical firms continue to Favor gelatin capsules for filling formulations; however, growing consumer concern over plant-based capsules is anticipated to further propel the market.
2. Antibiotics and antibacterial medications, which held the greatest share of the empty capsule market, are being consumed at higher rates due to the rising frequency of infectious and chronic diseases.
3. Since gelatin capsules provide the medication ingredient with greater stability and inertness, 70% of the empty capsules that are swallowed are composed of gelatin.
4. Increased dietary supplement intake is a major factor driving the market for empty capsules.
5. Because more people are becoming aware of the origins of the raw materials used to make gelatin-based capsules, vegetarian capsules made of HPMC have emerged.
Frequently Asked Questions
1. What is the market size of Empty Capsules Market in 2022?
2. Which are the top companies operating within the market?
3. Which region dominates the Empty Capsules Market?
Empty Capsules Market Segmental Analysis
By Application
Vitamin & Dietary Supplements
Antibiotic & Antibacterial Drugs
Cardiac Therapy Drugs
Antacids & Anti-flatulent preparations
Others
Procure complete report- https://wemarketresearch.com/purchase/empty-capsules-market/1320?license=single
By End-User
Pharmaceutical Companies
Nutraceutical Manufacturers
Others
Country Scope
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria
By Type
Gelatin
Non-Gelatin Capsules
Hydroxypropyl Methylcellulose (HPMC)
Others
By Functionality
Immediate Release
Sustained Release
Delayed Release
Empty Capsules Market Competitive Outlook
Lonza, Qualicaps, Suheung Co., Ltd, Roxlor Llc, Natural Capsules Limited, Nectar Lifesciences Ltd, Healthcaps India Ltd., Sunil Healthcare Limited, Bright Pharma Caps, Snail Pharma Industry Co. Ltd, Medi-Caps Ltd.
About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. WE MARKET RESEARCH is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.
Contact Us:
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: [email protected]
Related Articles:
Cellular IoT Market- https://medium.com/@mrunalini.wemarketresearch/cellular-iot-market-overview-size-share-opportunities-and-challenges-by-major-players-2024-2033-413c2ed61231
[206 Pages Report] MarketsandMarkets forecasts the Empty Capsules market to grow from USD 1.95 billion in 2018 to USD 2.79 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period.
A softgel consists of a gelatin-based shell surrounding a liquid or semi-solid (inner fill) drug or extract in the center.
Softgel capsules offer several benefits to consumers such as convenience, enhanced efficacy, and bioavailability.
Enteric softgel capsules are expected to exhibit significant market growth during the forecast period, owing to rise in adoption of enteric softgel, surge in demand for omega-3 supplements, growth in promotional activities by manufacturers, and rise in consumer awareness for preventative healthcare.
The global softgel capsules market is estimated to grow at a CAGR of approximately 5% during the forecast period to reach approximately USD 2.5 billion by 2025.Market Dynamics1.
Over the years, capsule delivery has witnessed a number of technological advancements in terms of product enhancements for better quality outcomes and patient comfort.
According to the new market research report “Empty Capsules Market by Type (Gelatin (Porcine, Bovine), Non gelatin (HPMC, Pullulan)), Functionality (Delayed release), Application (Antibiotics, Dietary Supplements, Anti- Inflammatory), End User (Pharma, Nutraceuticals) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period.Browse and in-depth TOC on “Empty Capsules Market”176 – Tables40 – Figures216 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190The overall growth of the Empty Capsules Market is largely driven by the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market, increasing R activities & clinical trial studies, and advancements in capsule delivery technologies.
Emerging markets, with their low manufacturing costs, are expected to present significant opportunities for players.
Other areas of opportunity are the development of halal gelatin and vegetarian capsules.Gelatin accounted for the largest share of Empty Capsules MarketBased on type, the market is categorized into gelatin capsules and non-gelatin capsules.
The various advantages of gelatin capsules, such as rapid drug release, uniform mixing of drugs, and a barrier to atmospheric oxygen (preventing oxidation of drug molecules), make them a preferred choice for manufacturing capsule shells.Immediate-release capsules accounted for the largest share of Empty Capsules MarketBased on functionality, the market has been segmented into immediate-release, sustained-release, and delayed-release capsules.
This is because immediate-release capsules are widely used to manufacture antibiotics, antibacterial, antacids, painkillers, inhalators, cold and cough drug preparations, and dietary supplements.Antibiotic & antibacterial drugs accounted for the largest share of marketBased on therapeutic applications, the market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations (hematinic), anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other therapeutic applications.
The antibiotic & antibacterial drugs segment accounted for the largest share of 33.1% of the Empty Capsules Market in 2020.The dietary supplements segment is expected to witness the highest CAGR of 8.2% during the forecast period.
